Beate Eckes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Beate Eckes has a total of 212 co-authors. Here are the top co-authors by number of shared publications:
Thomas Krieg
Translational Matrix Biology, University of Cologne, Medical Faculty, Cologne, Germany; Center for Molecular Medicine (CMMC), University of Cologne, Cologne, Germany; Cologne Excellence Cluster on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), University of Cologne, Cologne, Germany
19 shared publications- Julian Nüchel
University of Cologne
7 shared publications - Jan-Niklas Schulz
Department of Dermatology, University of Cologne, Cologne, Germany
6 shared publications - Thomas Krieg
Center for Molecular Medicine Cologne (CMMC), University of Cologne
6 shared publications Anja Niehoff
Cologne Center for Musculoskeletal Biomechanics, University of Cologne, Medical Faculty, Cologne, Germany; Institute of Biomechanics and Orthopaedics, German Sport University Cologne, Cologne, Germany
5 shared publicationsKatrin Blumbach
B Department of Dermatology, University of Cologne , Cologne , Germany
5 shared publications
Latest Publications
- Open Access
A conserved cargo recognition mechanism establishes TANGO1 as a selective extracellu lar matrix cargo receptor
The endoplasmic reticulum (ER) orchestrates the secretion of extracellular matrix (ECM) proteins, many of which exceed the size of conventional transport vesicles and therefore require specialized export machinery. TANGO1, encoded by MIA3 , organizes ER exit sites for bulky cargo export, yet the molecular basis of cargo recognition and its relationship to the collagen-specific chaperone HSP47 remain unclear. Through quantitative secretome profiling of TANGO1- and HSP47-deficient fibroblasts, structural modeling, and binding analyses, we show that TANGO1 directly and selectively recognizes a defined subset of ECM proteins, including specific collagen and fibrillin isoforms, through a conserved tyrosine residue in its luminal MOTH domain, independently of HSP47. Novel MIA3 variants identified in individuals with previously undescribed skeletal dysplasia disrupt this cargo-binding interface, leading to selective intracellular retention of ECM proteins. These findings identify direct cargo recognition, rather than ER exit-site assembly, as the primary molecular defect underlying MIA3 /TANGO1-associated skeletal dysplasia. More broadly, our work establishes TANGO1 as a selective ECM cargo receptor that functions independently of HSP47, providing a new framework for understanding bulky cargo selection at the ER.
Open AccessA conserved cargo recognition mechanism establishes TANGO1 as a selective extracellu lar matrix cargo receptor
The endoplasmic reticulum (ER) orchestrates the secretion of extracellular matrix (ECM) proteins, many of which exceed the size of conventional transport vesicles and therefore require specialized export machinery. TANGO1, encoded by MIA3 , organizes ER exit sites for bulky cargo export, yet the molecular basis of cargo recognition and its relationship to the collagen-specific chaperone HSP47 remain unclear. Through quantitative secretome profiling of TANGO1- and HSP47-deficient fibroblasts, structural modeling, and binding analyses, we show that TANGO1 directly and selectively recognizes a defined subset of ECM proteins, including specific collagen and fibrillin isoforms, through a conserved tyrosine residue in its luminal MOTH domain, independently of HSP47. Novel MIA3 variants identified in individuals with previously undescribed skeletal dysplasia disrupt this cargo-binding interface, leading to selective intracellular retention of ECM proteins. These findings identify direct cargo recognition, rather than ER exit-site assembly, as the primary molecular defect underlying MIA3 /TANGO1-associated skeletal dysplasia. More broadly, our work establishes TANGO1 as a selective ECM cargo receptor that functions independently of HSP47, providing a new framework for understanding bulky cargo selection at the ER.
- Open Access
- 5 January 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 445 (1) , 114408
Matrix-mediated activation of murine fibroblast-like synoviocytes
- 5 January 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 445 (1) , 114408
Open AccessMatrix-mediated activation of murine fibroblast-like synoviocytes
- Open Access
- 1 January 2025
- Published by SCIE Publishing Limited in Fibrosis
- Vol. 3 (2) , 10008
Targeting Collagen Secretion as a Potential Therapeutic Strategy to Modulate Fibrosis
SCIEPublish is an international open-access journal publishing service provider run by SCIE Publishing Limited, dedicated to supporting and inspiring scientists or institutions/societies who aspire to publish high-quality journals.
- 1 January 2025
- Published by SCIE Publishing Limited in Fibrosis
- Vol. 3 (2) , 10008
Open AccessTargeting Collagen Secretion as a Potential Therapeutic Strategy to Modulate Fibrosis
SCIEPublish is an international open-access journal publishing service provider run by SCIE Publishing Limited, dedicated to supporting and inspiring scientists or institutions/societies who aspire to publish high-quality journals.
- Open Access
- 24 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
TANGO1 inhibitors reduce collagen secretion and limit tissue scarring
Uncontrolled secretion of ECM proteins, such as collagen, can lead to excessive scarring and fibrosis and compromise tissue function. Despite the widespread occurrence of fibrotic diseases and scarring, effective therapies are lacking. A promising approach would be to limit the amount of collagen released from hyperactive fibroblasts. We have designed membrane permeant peptide inhibitors that specifically target the primary interface between TANGO1 and cTAGE5, an interaction that is required for collagen export from endoplasmic reticulum exit sites (ERES). Application of the peptide inhibitors leads to reduced TANGO1 and cTAGE5 protein levels and a corresponding inhibition in the secretion of several ECM components, including collagens. Peptide inhibitor treatment in zebrafish results in altered tissue architecture and reduced granulation tissue formation during cutaneous wound healing. The inhibitors reduce secretion of several ECM proteins, including collagens, fibrillin and fibronectin in human dermal fibroblasts and in cells obtained from patients with a generalized fibrotic disease (scleroderma). Taken together, targeted interference of the TANGO1-cTAGE5 binding interface could enable therapeutic modulation of ERES function in ECM hypersecretion, during wound healing and fibrotic processes.
- 24 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
Open AccessTANGO1 inhibitors reduce collagen secretion and limit tissue scarring
Uncontrolled secretion of ECM proteins, such as collagen, can lead to excessive scarring and fibrosis and compromise tissue function. Despite the widespread occurrence of fibrotic diseases and scarring, effective therapies are lacking. A promising approach would be to limit the amount of collagen released from hyperactive fibroblasts. We have designed membrane permeant peptide inhibitors that specifically target the primary interface between TANGO1 and cTAGE5, an interaction that is required for collagen export from endoplasmic reticulum exit sites (ERES). Application of the peptide inhibitors leads to reduced TANGO1 and cTAGE5 protein levels and a corresponding inhibition in the secretion of several ECM components, including collagens. Peptide inhibitor treatment in zebrafish results in altered tissue architecture and reduced granulation tissue formation during cutaneous wound healing. The inhibitors reduce secretion of several ECM proteins, including collagens, fibrillin and fibronectin in human dermal fibroblasts and in cells obtained from patients with a generalized fibrotic disease (scleroderma). Taken together, targeted interference of the TANGO1-cTAGE5 binding interface could enable therapeutic modulation of ERES function in ECM hypersecretion, during wound healing and fibrotic processes.
- Open Access
- 26 March 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (10)
Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis
Transforming growth factor β (TGF-β) signaling is a core pathway of fibrosis, but the molecular regulation of the activation of latent TGF-β remains incompletely understood. Here, we demonstrate a crucial role of WNT5A/JNK/ROCK signaling that rapidly coordinates the activation of latent TGF-β in fibrotic diseases. WNT5A was identified as a predominant noncanonical WNT ligand in fibrotic diseases such as systemic sclerosis, sclerodermatous chronic graft-versus-host disease, and idiopathic pulmonary fibrosis, stimulating fibroblast-to-myofibroblast transition and tissue fibrosis by activation of latent TGF-β. The activation of latent TGF-β requires rapid JNK- and ROCK-dependent cytoskeletal rearrangements and integrin α V (ITGAV). Conditional ablation of WNT5A or its downstream targets prevented activation of latent TGF-β, rebalanced TGF-β signaling, and ameliorated experimental fibrosis. We thus uncovered what we believe to be a novel mechanism for the aberrant activation of latent TGF-β in fibrotic diseases and provided evidence for targeting WNT5A/JNK/ROCK signaling in fibrotic diseases as a new therapeutic approach.
- 26 March 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (10)
Open AccessNoncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis
Transforming growth factor β (TGF-β) signaling is a core pathway of fibrosis, but the molecular regulation of the activation of latent TGF-β remains incompletely understood. Here, we demonstrate a crucial role of WNT5A/JNK/ROCK signaling that rapidly coordinates the activation of latent TGF-β in fibrotic diseases. WNT5A was identified as a predominant noncanonical WNT ligand in fibrotic diseases such as systemic sclerosis, sclerodermatous chronic graft-versus-host disease, and idiopathic pulmonary fibrosis, stimulating fibroblast-to-myofibroblast transition and tissue fibrosis by activation of latent TGF-β. The activation of latent TGF-β requires rapid JNK- and ROCK-dependent cytoskeletal rearrangements and integrin α V (ITGAV). Conditional ablation of WNT5A or its downstream targets prevented activation of latent TGF-β, rebalanced TGF-β signaling, and ameliorated experimental fibrosis. We thus uncovered what we believe to be a novel mechanism for the aberrant activation of latent TGF-β in fibrotic diseases and provided evidence for targeting WNT5A/JNK/ROCK signaling in fibrotic diseases as a new therapeutic approach.
- 22 September 2022
- Published by Morressier GmbH
ESDR009 - Single cell RNA sequencing reveals specific subsets in Systemic Sclerosis fibroblast cultures.
Systemic sclerosis (SSc) is a chronic autoimmune disease causing vasculopathy and fibrosis in the skin and vital organs. Following an inflammator | POSTER
- 22 September 2022
- Published by Morressier GmbH
ESDR009 - Single cell RNA sequencing reveals specific subsets in Systemic Sclerosis fibroblast cultures.
Systemic sclerosis (SSc) is a chronic autoimmune disease causing vasculopathy and fibrosis in the skin and vital organs. Following an inflammator | POSTER
- Open Access
- 26 August 2021
- Published by Morressier GmbH
ESDR348 - Collagen-binding integrins are important for orchestrating tissue architecture and fibrotic responses
Collagens contribute to the mechanical stability of tissues, regulate cell fate and activities. Integrins α1β1, α2β1, α11β1 are the main collagen receptors in skin. Our previous work revealed their individual functions and also demonstrated compensatory mechanisms. We here address the overall significance of integrin-mediated cell-collagen association in vitro and in vivo using
- 26 August 2021
- Published by Morressier GmbH
Open AccessESDR348 - Collagen-binding integrins are important for orchestrating tissue architecture and fibrotic responses
Collagens contribute to the mechanical stability of tissues, regulate cell fate and activities. Integrins α1β1, α2β1, α11β1 are the main collagen receptors in skin. Our previous work revealed their individual functions and also demonstrated compensatory mechanisms. We here address the overall significance of integrin-mediated cell-collagen association in vitro and in vivo using
- Open Access
- 20 July 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-19
TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy
Activation of fibroblasts is essential for physiological tissue repair. Uncontrolled activation of fibroblasts, however, may lead to tissue fibrosis with organ dysfunction. Although several pathways capable of promoting fibroblast activation and tissue repair have been identified, their interplay in the context of chronic fibrotic diseases remains incompletely understood. Here, we provide evidence that transforming growth factor-β (TGFβ) activates autophagy by an epigenetic mechanism to amplify its profibrotic effects. TGFβ induces autophagy in fibrotic diseases by SMAD3-dependent downregulation of the H4K16 histone acetyltransferase MYST1, which regulates the expression of core components of the autophagy machinery such as ATG7 and BECLIN1. Activation of autophagy in fibroblasts promotes collagen release and is both, sufficient and required, to induce tissue fibrosis. Forced expression of MYST1 abrogates the stimulatory effects of TGFβ on autophagy and re-establishes the epigenetic control of autophagy in fibrotic conditions. Interference with the aberrant activation of autophagy inhibits TGFβ-induced fibroblast activation and ameliorates experimental dermal and pulmonary fibrosis. These findings link uncontrolled TGFβ signaling to aberrant autophagy and deregulated epigenetics in fibrotic diseases and may contribute to the development of therapeutic interventions in fibrotic diseases.
- 20 July 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-19
Open AccessTGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy
Activation of fibroblasts is essential for physiological tissue repair. Uncontrolled activation of fibroblasts, however, may lead to tissue fibrosis with organ dysfunction. Although several pathways capable of promoting fibroblast activation and tissue repair have been identified, their interplay in the context of chronic fibrotic diseases remains incompletely understood. Here, we provide evidence that transforming growth factor-β (TGFβ) activates autophagy by an epigenetic mechanism to amplify its profibrotic effects. TGFβ induces autophagy in fibrotic diseases by SMAD3-dependent downregulation of the H4K16 histone acetyltransferase MYST1, which regulates the expression of core components of the autophagy machinery such as ATG7 and BECLIN1. Activation of autophagy in fibroblasts promotes collagen release and is both, sufficient and required, to induce tissue fibrosis. Forced expression of MYST1 abrogates the stimulatory effects of TGFβ on autophagy and re-establishes the epigenetic control of autophagy in fibrotic conditions. Interference with the aberrant activation of autophagy inhibits TGFβ-induced fibroblast activation and ameliorates experimental dermal and pulmonary fibrosis. These findings link uncontrolled TGFβ signaling to aberrant autophagy and deregulated epigenetics in fibrotic diseases and may contribute to the development of therapeutic interventions in fibrotic diseases.
- 1 April 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (4) , 1076-1086.e3
miR-127-3p Is an Epigenetic Activator of Myofibroblast Senescence Situated within the MicroRNA-Enriched Dlk1-Dio3‒Imprinted Domain on Mouse Chromosome 12
- 1 April 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (4) , 1076-1086.e3
miR-127-3p Is an Epigenetic Activator of Myofibroblast Senescence Situated within the MicroRNA-Enriched Dlk1-Dio3‒Imprinted Domain on Mouse Chromosome 12
- 1 December 2020
- Published by Elsevier in Matrix Biology
- Vol. 94, 57-76
Role of collagen XII in skin homeostasis and repair
- 1 December 2020
- Published by Elsevier in Matrix Biology
- Vol. 94, 57-76
Role of collagen XII in skin homeostasis and repair